Curative effect and observation of adenomyosis treated with levonorgestrel-releasing intrauterine device
article
OA: closed
CC0
AI-generated summary
This study evaluated the clinical effects of levonorgestrel-releasing intrauterine devices in 74 adenomyosis patients, finding significant reductions in pelvic pain, menstrual blood loss, and uterine volume over an 18-month period.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective To investigate the clinical effection of levonorgestrel-releasing intrauterine device(LNG-IUS) in the treatment of adenomyosis.Methods Before LNG-IUS insertion and after 3,6,12,18 months,74 cases were asked to complete a visual analog scale(VAS) form regarding pelvic pain,pictorial blood loss assessment chart(PBAC) form regarding menstrual blood volume and volume of uterus.Results After the 18-month visit,VAS score,PBAC score and volume of uterus were 0.74,42.7,206.5cm3,respectively.There were decreased significantly before LNG-IUS insertion(P0.05).Conclusion Levonorgestrel intrauterine device is a preferable effective method in the treatment of adenomyosis.
My notes (saved in your browser only)
Outcome instruments
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK